Status: Enrolling
Investigator: Sheetal Shroff
Study Coordinator: KaDeesia Brown
Phone: 713.441.9120
In Amyotrophic Lateral Sclerosis (ALS), the reduction of regulatory T lymphocyte (Treg) numbers and suppressive function correlates with rapid disease progression. We completed a phase 1 study of infusions of expanded autologous Tregs in combina ... Read more >
Status: Enrolling
Investigator: Stanley Appel
Study Coordinator: Anjana Singh
Phone: 713.441.9120
The purpose of this protocol is to develop and maintain a biospecimen bank comprised of blood, urine, CSF collected during diagnostic evaluations, tissue from biopsies and autopsies collected from patients with neurological disease and non-neu ... Read more >
Status: Open Not Enrolling
Investigator: Stanley Appel
Study Coordinator: KaDeesia Brown
Phone: 713.441.9120
The purpose of this protocol is to develop and maintain a clinical findings data bank including diagnostic evaluations obtained from medical records sent from prior medical evaluations, diagnostic intake evaluations and follow-up care in the Met ... Read more >
Status: Open Not Enrolling
Investigator: Stanley Appel
Study Coordinator: Sharon Halton
Phone: 713.441.3420
The purpose of the this study to look for abnormal genes and gene expression profiles that help determine why a person develops amyotrophic lateral sclerosis (ALS) and related motor neuron diseases (MND) and why their symptoms present and progre ... Read more >
Status: Enrolling
Investigator: Sheetal Shroff
Study Coordinator: Anjana Singh
Phone: 713.441.9120
The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS. ... Read more >
Status: Open Not Enrolling
Investigator: Sheetal Shroff
Study Coordinator: Aramide Balogun
Phone: 713.441.6955
The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS. Regimen A will evaluate the safety and efficacy of a single study ... Read more >
Status: Open Not Enrolling
Investigator: Stanley Appel
Study Coordinator:
Phone:
The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS. Regimen B will evaluate the safety and efficacy of a single study ... Read more >
Status: Open Not Enrolling
Investigator: Stanley Appel
Study Coordinator: Bing Liao
Phone: 713.363.7310
The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS. Regimen C will evaluate the safety and efficacy of a single study ... Read more >